US FDA to take steps to help gene therapies get accelerated approval
(Reuters) -The U.S. Food and Drug Administration is moving to optimize the development of gene therapies, including encouraging the use of biomarkers to help get accelerated approval of therapies for serious conditions, an agency official said. Biomarkers, such as pulse and blood pressure, are characteristics of the body that you can measure. The FDA will …
US FDA to take steps to help gene therapies get accelerated approval Read More »